Skip to main content
Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
16.45
-0.50 (-2.95%)
At close: Mar 9, 2026, 4:00 PM EDT
16.48
+0.03 (0.18%)
After-hours: Mar 9, 2026, 7:48 PM EDT

Tango Therapeutics Revenue

In the year 2025, Tango Therapeutics had annual revenue of $62.38M with 48.29% growth.

Revenue (ttm)
$62.38M
Revenue Growth
+48.29%
P/S Ratio
37.63
Revenue / Employee
$455,358
Employees
137
Market Cap
2.35B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202562.38M20.32M48.29%
Dec 31, 202442.07M5.54M15.17%
Dec 31, 202336.53M11.67M46.93%
Dec 31, 202224.86M-12.18M-32.89%
Dec 31, 202137.04M29.39M383.83%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Telix Pharmaceuticals 803.79M
Ultragenyx Pharmaceutical 673.00M
Adaptive Biotechnologies 276.98M
Iovance Biotherapeutics 263.50M
Stoke Therapeutics 205.63M
Day One Biopharmaceuticals 158.18M
Ocular Therapeutix 51.95M
Wave Life Sciences 42.73M
Revenue Rankings

TNGX News

More News